Exploration the feasibility and additional value of [<sup>18</sup>F]FDG/[<sup>68</sup>Ga]Ga-FAPI-04 dual-low-activity-tracer one-stop total-body PET imaging at 34 min post-injection of [<sup>68</sup>Ga]Ga-FAPI-04.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 39320482.
- Also identified by DOI 10.1007/s00259-024-06924-2.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To validate the feasibility of one-stop 2-[<sup>18</sup>F]fluoro-2-deoxy-D-glucose ([<sup>18</sup>F]FDG) and [<sup>68</sup>Ga]Ga-fibroblast activation protein inhibitor-04 ([<sup>68</sup>Ga]Ga-FAPI-04) dual-low-activity-tracer positron emission tomography/computed tomography (PET/CT) at 34 min post-injection of [<sup>68</sup>Ga]Ga-FAPI-04 and explore its additional value. Thirty pairs of patients with suspected malignancies who underwent dual-tracer imaging were enrolled in this retrospective study. The images were reconstructed at 34-39 and 50-60 min after additional injection of [<sup>68</sup>Ga]Ga-FAPI-04 (in one-stop FDG-FAPI PET/CT, named PET<sub>FDG</sub>, PET<sub>D34-39</sub>, and PET<sub>D50-60</sub>; in the 2-day protocol, named PET<sub>FDG'</sub>, PET<sub>F34-39</sub>, and PET<sub>F50-60</sub>, respectively). Tumour-to-normal ratios (TNR) of lesions in PET<sub>FDG</sub>, PET<sub>D34-39</sub>, and PET<sub>D50-60</sub> and TNR of lesions in PET<sub>F34-39</sub> and PET<sub>F50-60</sub> were evaluated separately. To evaluate the potential added value of one-stop FDG-FAPI PET/CT over the 2-day protocol, TNRs of PET<sub>FDG</sub>, PET<sub>D34-39</sub>, and PET<sub>D50-60</sub> were compared with PET<sub>F34-39</sub>. The lesion detectability of the two imaging protocols was evaluated by chi-square test. Comparing FAPI-weighted PET (PET<sub>D34-39</sub> and PET<sub>D50-60</sub>) and single-tracer imaging (PET<sub>FDG</sub>) in one-stop FDG-FAPI PET/CT, TNRs of FAPI-weighted PET were higher than those of PET<sub>FDG</sub>. PET<sub>D34-39</sub> and PET<sub>D50-60</sub> showed similar performance in lesion detectability and TNRs (all P > 0.05). In the 2-day protocol, there are no statistically significant differences in TNRs of all lesions at PET<sub>F34-39</sub> and PET<sub>F50-60</sub>. Comparing one-stop FDG-FAPI PET/CT with the 2-day protocol, TNRs of PET<sub>F34-39</sub> were significantly higher than those of PET<sub>FDG</sub> but lower than those of PET<sub>D34-39</sub> and PET<sub>D50-60</sub>. Lesion detectability in the one-stop FDG-FAPI PET/CT was higher than that in the 2-day protocol. The average radiation dose in one-stop FDG-FAPI PET/CT was significantly lower than that in the 2-day protocol (P<0.001). One-stop FDG-FAPI PET/CT at 34 min could provide sufficient information to meet clinical diagnosis and showed better lesion detectability than that in the 2-day protocol.
Medical subject headings
- Fluorodeoxyglucose F18
- Positron Emission Tomography Computed Tomography
- Whole Body Imaging